Helix BioPharma Corp. Announces That Institutional Shareholder Services Recommends Shareholders Vote for Management's Director Nominees

Helix BioPharma Corp. HBP is pleased to announce that Institutional Shareholder Services has recommended that shareholders vote FOR the slate of directors nominated by management, which includes Jack M. Kay, W. Thomas Hodgson, Donald H. Segal, Ewa Don-Siemion, Wojciech M. Kwiatek and Wayne Schnarr, at the upcoming annual meeting on January 30, 2012. ISS is a leading independent international corporate governance analysis and proxy voting firm. Its recommendations assist shareholders in making decisions regarding proxy voting. In their analysis, ISS stated: "Ultimately we are not convinced that wholesale board change is warranted at this time. Furthermore, it is not obvious that the dissident nominees would be better able to create value than the current board."